/
Managing Frailty  Ginny Managing Frailty  Ginny

Managing Frailty  Ginny - PowerPoint Presentation

Muscleman
Muscleman . @Muscleman
Follow
342 views
Uploaded On 2022-08-03

Managing Frailty  Ginny - PPT Presentation

Winstanley GP PCN CD West Kent GP lead for Frailty and Local Care Owen Ingram Consultant Geriatrician MTW Amy Heskett Associate Specialist in Geriatrics Home Treatment Service ID: 933301

care frailty drug patients frailty care patients drug mdt treatment kmcr kent avoid support dementia gps admissions elderly medications

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Managing Frailty  Ginny" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Managing Frailty 

Ginny

Winstanley

(GP, PCN CD, West Kent GP lead for Frailty and Local Care)

Owen Ingram

(Consultant Geriatrician MTW)

Amy

Heskett

(Associate Specialist in Geriatrics, Home Treatment Service)

Deirdre McCauley, Helen Terrell, Jenny Brown

(Frailty GPs, West Kent Primary Care)

Slide2

Agenda

West Kent Frailty service update - Proactive and reactive services and the plan for West Kent

Frailty GPs - how can they help you?

Prescribing and frailty 

Treatment escalation planning

KMCR- What is it and why should we use?

Q+A

Slide3

National Context

Long Term Plan & Ageing Well Programme

An overview: Ageing Well Programme

More joined up, coordinated care with a much stronger emphasis on proactive care

Deliver integrated, personalised care in communities via three key focus areas

Care makes sense to people and they get what they need when they need it

Slide4

Local Context

West Kent has c. 11,100 people with high or very high levels of frailty

The growth in the severe frail population between 2020 and 2030 is expected to be 24.6% in West Kent, (or an additional 2,741 people).

The expected increase in numbers with multiple and complex needs is more modest at 9.8%.

The incidence of dementia is expected to grow by 17% between 2020 and 2030

Slide5

What can we do?

RECOGNITION! Identify and code

Comprehensive Geriatric Assessment

Multicomponent, Multidisciplinary assessments

Medical, Drugs, Cognition, Psychiatric, Mobility, Functional, Continence, Advanced care plans,Doctors, Nurses, PAs, OT, Physio, SALT, Pharmacy, Social servicesAnticipatory Care planning Refer to frailty teams!

Slide6

Frailty Definition

Oxford English Dictionary:

The condition of being weak and delicate

Is it normal ageing?

Is it helpful or perjorative?Medical Definition?

Slide7

WHO Healthy Ageing

“The process of developing and maintaining the functional ability that enables wellbeing in older age”

meet their basic needs;

to learn, grow and make decisions;

to be mobile;to build and maintain relationships; andto contribute to societyIt requires ‘intrinsic capacity’ of the individual and relevant environmental characteristics

Slide8

What is frailty?

A syndrome of physiological decline in late life, leading to an increased vulnerability to poor resolution of homeostasis after a stressor event

Slide9

Models of frailty?

Phenotype Model (Fried 2001):

unintentional weight loss,

exhaustion,

muscle weakness,slowness while walking, andlow levels of activityThe phenotype model is a precursor to Rockwood’s Clinical Frailty Scale

Slide10

Clinical Frailty Scale

Slide11

Slide12

Models of Frailty?

Frailty Syndrome

Fallers

Patients with delirium

Patients with immobilityPatients with incontinencePatients with polypharmacy / drug side effectsCare home resident

Slide13

The Goal

Slide14

West Kent Frailty Services

REACTIVE

Acute Frailty Units

Home Treatment Service

Primary CarePROACTIVEFrailty MDTsEnhanced Health in Care Homes

Slide15

Acute Frailty Unit - MTW

Maidstone and Tunbridge Wells Frailty Units

2 Acute Frailty Units

Maidstone

9 assessment beds on Whatman WardTunbridge Wells7 bedded assessment area on Ward 2Opening hours8am-8pm Monday-Friday8am-6pm Saturday-Sunday

Slide16

Acute Frailty Unit Metrics

TWH

Seeing 60-70 patients per week

50% discharged on the same day

MaidstoneSeeing 50-60 patients per week50% discharged on the same dayRe-admissionsNo increase in re-admissions since AFUs openedSignificant reduction in LOS since AFUs opened

Slide17

Pathways

ED pathway to AFU:

All patients >70 screened using CFS by triage / Rapid assessment (RAP)

Direct referral from RAP

clinican to AFUAll patients with Frailty screened by AFU team to see if appropriateSECAM to AFU:Direct referral from paramedics (1-2/day each site)Home Treatment Team / Frailty GPs:Community patients for Admission (or ED) avoidance

Slide18

Home Treatment Service

Slide19

Home Treatment Service

03000 247111

Slide20

PCN Frailty MDTs

Running since Sep 2017

Twice monthly meetings per PCN, via MS Teams

Include:

- MDT Coordinators - Frailty Nurses/Complex Care Nurses - Physiotherapy - MDT pharmacists - Dementia Nurses - Health and Social Care Coordinators - Social Services - Geriatrician - Frailty GPsSupported by : Age UK, Kent Fire and Rescue

Slide21

MDT Referrals April 2021 – January 2022

PCN

April

May

June

July

August

 

September

 

 

October

 

November

 

December

 

January

 

Referrals received

ABC

12

14

13

12

13

19

19

21

17

8

148

Maidstone Central

24

20

28

21

18

20

22

19

25

25

222

Maidstone South

17

15

19

25

5

15

19

29

6

21

171

Malling

10

5

7

7

4

13

7

1571287Sevenoaks24172419172518241722207The Ridge13171091115123990Tonbridge18141920162624212710195Tunbridge Wells44403031443032333229345Weald11212617151116152121174Grand Total1731631761611331701621891551571639

CGAs

Slide22

Slide23

Slide24

Emergency Attendances

Start Date: 1st April 2016

NHS Trust: MTW Only

CCG: West Kent CCG Only

Cohort of patients discussed in MDT: Between 1

st

January 2019 to 31

st

August 2019 Age: 60+

Number of patients: 715

A&E

MIU

Total

 

Admissions 12m before

2310

30

2340

 

Admissions 12m after

2026

18

2044

 

Increase/Decrease of

-284

-12

-296

 

% of Increase/Decrease

-12%

-40%

-13%

 

Slide25

Slide26

78

Respondants

MDT Experience: 78% extremely good/good, 6% poor/extremely poor.

MDT teams and services working well together 80% positive, 5% negative57% respondants felt effectiveness and quality of the MDT meetings improved compared to 12 months ago, 37% felt as though it has remained the samePatient identification: 46% felt as though it was easy, 20% difficult. MDT User Survey June 2021

Slide27

What next?

1. Improving Identification of patients

Aim to increase proactive care after reactive episodes. What went wrong? What next?

Improving follow up of patients following unplanned admissions:

- CCNs in board roundsFrailty teams to review lists of over 80s with unplanned admissions Review of care home admissions2. Developing PCN frailty teams to support GPs and streamline working between teamsMove to set meeting days per PCN to allow continuity of MDT staffTriaging of referrals and coordinated approach to assessmentsFrailty GPs to support actions practice EMIS systems3. Additional ServicesDementia Care CoordinatorsIncreased hospice support with care planning

Slide28

Frailty

GPwER

project

Since Jan 2020

2 WTE Frailty GPs recruited to support MDTs and pro-active care within PCNs9 GPs working towards accreditation to become frailty GPwERs Weekly meetings to discuss cases with Frailty consultant and Home Treatment ServiceFacilitate admissions to Frailty Unit from primary care. Worked with HTS during pandemicSupporting training of ANPs working with MDTs via joint visitsProviding geriatric reviews and care planning for those patients unable to get to outpatients or GP surgeriesAim to work alongside dementia GPwERs to support dementia diagnosis and treatment in the communityChampions for KMCR within primary care, aiming for rapid adoption and in sharing MDT outcomes and and care planning with acute and out of hours providers

Slide29

Frailty GP

Slide30

Frailty GP service

7 GPs

7 hrs per week per PCN

Weekly supervision to discuss difficult cases

Integrated into community teams via MDT and HTS

Integrated into hospital teams via the frailty unit

Slide31

What we do

Slide32

How can we help you

Most referrals from MDT

Review of the more complex medical problems.

Support with care planning discussions

Discussions around capacity and adult safeguarding

Arrange investigations via the frailty unit for pts unable to access through usual routes

Slide33

Pharmacology and Frailty

Dr Owen Ingram

Consultant Geriatrician and Physician MTW

Frailty Lead Consultant

Slide34

Objectives

To understand the principles of safe prescribing for the older patient

The increased use of drugs in elderly patients and the increase on adverse drug reactions

The effect of the ageing process on pharmacokinetics and pharmacodynamics

Factors affecting compliance The rules for rational prescribing for elderly people

Slide35

Polypharmacy

Defined as:

Taking 5 or more regular medications

Or as

'Appropriate Polypharmacy' vs 'Problematic Polypharmacy'

Slide36

Slide37

Polypharmacy

in the Elderly

16% of over 65s taking >10 medications

Elderly patients in hospital

Average take 6 regular medicationsIncrease by 3 medications on dischargeElderly patients in nursing homesAverage 8 regular medicationsTrials often don't include frail, elderly patients with co-morbidities

Slide38

Adverse drug reactions

Each additional medication increases the risk of errors

A nursing home study showed 70% of residents were exposed to a drug error

Adverse drug reactions cause:

6.5% of hospital admissions (increasing to 10% in the over 65s)Median length of stay 8 days0.15% mortality rateCommonest implicated medications:Aspirin, NSAIDs, anticoagulantsDiureticsDiabetic drugs

Slide39

Pharmacokinetic implications of Ageing

Route of Administration

Distribution

Metabolism

AbsorptionElimination

Slide40

Pharmacokinetic implications of Ageing

Route of Administration

Distribution

Metabolism

AbsorptionElimination

Dysphagia, Delirium, Compliance

Inflammation /

Polypharmacy

Low albumin, low body water

Reduced liver function / I and IsReduced eGFR

Slide41

Factors hindering safe prescribing:

Heterogenic

cormorbid

patient groupIncreasing prevalence of polypharmacyLimited applicable evidence and trials in this cohortHigh incidence of adverse drug reactionsUnpredictable pharmacokinetics complicated by polypharmacyCompliance and cognitive impairmentHealthy ageing vs frailty

Slide42

Prescribing advise in the elderly

Is the indication still relevant?

Concentrate on QOL not disease specific prescribing

Start slow and low

Avoid starting 2 drugs simultaneouslyAvoid co-prescribing antagonistic drugsConsider non-pharmacological options or other routesInclude drug side effects in the differential diagnosisTry not to treat drug side effects with extra drugs

Slide43

Preventative Medicine

Avoiding side effects

Slide44

Indicators that a medication review is required?

Adverse drug reaction

>10 regular medications

Falls:

Increased incidence of falls in those >4 medicationsMedication review shown to reduce falls riskMarkers of frailtyNew palliative diagnosis

Slide45

Validated tools to review

polypharmacy

Beer's Criteria

Recommended list of drugs to avoid in elderly people – with reasons

http://www.americangeriatrics.org/files/documents/beers/BeersCriteriaPublicTranslation.pdfSTOPP / START criteriaScreening tool of older persons potentially inappropriate prescriptionsScreening tool to alert to right treatmentDeprescribing.orgAlgorithms for safely deprescribing PPIs, benzos and antipsychoticsAnticholinergic risk scaleScale categorising anticholinergic burden of specific drugs

Slide46

Clinical Scenario

Mrs RC is a 94yo nursing home resident with a past history of stroke, hypertension and dementia. Her regular medications are:

Aspirin 75mg OD Dipyridamole 200mg OD

Atorvastatin

80mg OD Amlodipine 10mg ODBendroflumethiazide 2.5mg OD Donepezil 5mg ODAmitripylline 10mg OD 2 weeks ago she developed abdominal pain, urinary incontinence and agitation. She was started on:Oxybutinin 2.5mg OD Risperidone 0.5mg BDOn review today she is drowsy and her oral intake has reduced. What could have been done differently to avoid this deterioration?

Slide47

Clinical Scenario Take 2

Mrs RC is a 94yo nursing home resident with a past history of stroke, hypertension and dementia. Her regular medications are:

Clopidogrel 75mg OD

Dipyridamole 200mg OD

Atorvastatin 20mg OD Amlodipine 10mg ODBendroflumethiazide 2.5mg OD Donepezil 5mg ODAmitripylline 10mg OD 2 weeks ago she developed abdominal pain, urinary incontinence and agitation. She was started on:Oxybutinin 2.5mg OD Risperidone 0.5mg BDMovicol 1 sachet once dailyA bowel and bladder chart with PRN laxativesParacetamol 1g QDSToday her agitation has resolved and she has occasional accidents

Slide48

Compliance in the elderly

50% of prescribed medications not taken

Why?

Patient Factors

Medication FactorsHealthcare FactorsCognitive impairmentPolypharmacyPatient educationSensory deficitsPoor labellingRegular follow upLack of caregiver

Side effectsPatient involvement

Slide49

Techniques to aid compliance

Educate and empower patients

Simplify drug regimes

Discuss regimes with carers

Inform of early side effectsEncourage use of drug diariesUse large print on bottles, that are easy to openMonitored Dosage SystemsTelemedicineCovert administration

Slide50

Slide51

Top tips and common pitfalls - Bladder

Anticholinergics for overactive bladder:

Avoid if possible unless clear benefit and consider mirabegron

Stop if dementia / delirium

Don’t co-prescribe with donepezilConsider non-pharmacological management of incontinenceStop if history of urine retention or catheterisedTamsulosinLong term catheter negates need for tamsulosinIf postural hypotension consider finasterideRecurrent UTIAvoid long term AbxConsider topical oestrogens

Slide52

Top tips and common pitfalls - BP

Nitrates and Nicorandil in fallers

Do they still suffer with angina? Have they had a recent cardiac event?

Do they really still need the vasodilators?

Swollen legs and furosemide didn’t help?Maybe its venous insufficiencyCould we stop his amlodipine?Digoxin 250mcg is a red flag – drop it 125mcgSupine hypertension with postural hypotensionNo right answer, no good evidenceInvolve the patient in decision on continuing antihypertensivesAccept a higher BP target

Slide53

Top tips and common pitfalls – Blood thinners

Dual antiplatelets

Has a year gone by since their MI

Aspirin and

dipyrimadoleSwitch to clopidogrelAnticoagulation and antiplateletIs this a specialist recommendation or did the physician on call forget to stop the aspirin when they diagnosed them with AFAnticoagulation and fallsIn general patients need to be falling a lot before you consider stopping their anticoagulation….I get worried when its >1 per week

Slide54

Top tips and common pitfalls – Brain drugs

Benzodiazepines

Avoid and try and stop – consider melatonin if sleep a concern

Antipsychotics in dementia with BPSD

Avoid if possibleDeprescribe if symptoms improve (don’t just continue ad infinitum)Antipsychotics in schizophrenia / psychotic depressionWhen did they last have a major psychotic episode?Is it worth asking an old age psychiatrist if its time to reduce the dose?Phenytoin and barbituratesIf their last seizure was before you graduated medical school its time to ask the neurologist if we can reduce / stop itAmitriptyline – surely there is a cleaner drug for the job

Slide55

Top tips and common pitfalls – Miscellaneous

Betahistine

Unless they truly do have Meniere’s try not to use it long term

Are you sure they don’t have BPPV?

StatinsIs it primary or secondary prevention?Are they in the last year of their life with severe frailty?NSAIDsAvoid at all costsInsulin and oral hypoglycaemics, in advanced dementia / frailty with variable oral intakeOften requirements reduceAim to avoid hypos and symptomatic hyperglycaemia (not HbA1C)

Slide56

Any Questions?

Slide57

References

The King's Fund:

Polypharmacy

and medicines optimisation 2013

Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients. Pirmohamed et al 2004A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Alhawassi 2014Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Mangoni et al 2004Assessment of Renal insufficiency in patients with normal serum creatinine levels undergoing coronary angiography Mujtaba et al 2010Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes NICE 2015Deprescribing.orgIdentifying Medications that Older Adults Should Avoid or Use With Caution: the 2012 American Geriatrics Society Updated Beers CriteriaADHERENCE TO LONG-TERM THERAPIES Evidence for action. WHO 2003Caring for older people: Aids for Compliance with medicationEnsuring appropriate use of monitored dosage systems: reducing unnecessary pharmacy workload. Nice Quality and Productivity 2015Medicines Management in Care Homes: NICE Guidelines 2015

Slide58

TREATMENT ESCALATION PLANNING

WHAT?

WHY?

WHEN?

HOW?

Slide59

Slide60

WHY DO A TEP?

To avoid acute admissions for those living with frailty or long term conditions.

 

If

in line with a person’s goals in place of their choosing.To provide practical support to allow the above 

Slide61

WHEN TO DO A TEP?

Multiple admissions associated with a reduction in function

When care needs are hard to replicate in a hospital

Person expresses a desire to avoid admission

In context of frailty or multiple long-term conditions

Slide62

6%

11%

24%

RISK OF DEATH DURING HOSPITAL ADMISSION BASED ON DEGREE OF FRAILTY

Slide63

BE BRAVE

BE KIND

BE CURIOUS

ALLOW TIME

HOW TO DO A TEP?

Slide64

-

What makes a good day?

-If you were very poorly what should we focus on?

-if you were so unwell and you could not speak- what would your wishes be?

Slide65

Hospital could be an option if:

SEE AS A MENU!

-heavy bleeding

-broken bone

-if carers/family are not able to support care needs-if worsening despite treatment at home-hospital based investigations required

Slide66

Slide67

2AM TEST…….

WOULD THIS TEP BE USEFUL AT 2AM FOR A PARAMEDIC CREW?

Slide68

List common scenarios

Slide69

ReSPECT

Document

Slide70

ReSPECT aims to:

put each individual at the centre of the conversation

shared understanding between person and clinician

focus on treatments to be given, not just one to be withheld record agreed clinical recommendations be recognised across all boundaries

Slide71

How was

ReSPECT

developed?

Many individual stakeholders

(e.g. patients, doctors, nurses, ambulance clinicians) Representatives of many stakeholder organisations Integrated ethical and legal best practice

Responded to feedback from users

Support from Resuscitation Council UK

Continued evolution in response to feedback

Slide72

https://www.youtube.com/watch?v=SdkncGjihG0

Slide73

KMCR

Slide74

Slide75

KMCR

Key Benefits in management of patients with frailty and complex care:

Shared electronic record of Treatment escalation plans

Shared record of MDT meetings

Shared record of frailty assessments

Slide76

KMCR

Slide77

What is KMCR?

The Kent and Medway Care Record (KMCR) will give staff access to shared patient information from across health and social care by providing a shared care record solution.

The KMCR contains data from multiple health and social care systems, joins it up at patient level, and displays the information in one place for the benefit of staff and citizens. The KMCR includes data from:

 GPs Acute Trusts Community Trusts

Local Authorities

Mental Health Trusts

Out of Hours Services

Ambulance Services

HospicesThe information available in your instance of KMCR depends on local preferences and maturity of the project within your organisation.

The system access you have will be determined by the RBAC (Role Based Access Control) role you have been assigned by your organisation, this will either an Admin or Clinical Role.

 

Slide78

Integrated Health and Social Care for Kent & Medway

Slide79

EMIS SSO Login

The screenshot below is an example of an EMIS SSO login with screenshots from a GP Practice. Always make sure you are in the Care Record before accessing KMCR.

Slide80

Slide81

Contingency plan 1/2

Slide82

Contingency plan 2/2

Slide83

Epaccs

1/6

Slide84

Epaccs

2/6

Slide85

Epaccs

3/6

Slide86

Epaccs

4/6

Slide87

Epaccs

5/6

Slide88

Epaccs

6/6

Slide89

Q+A